Navigation Links
length in Medical Technology

Hospital Care Varies Greatly for Children with Urinary Tract Infections

... of care," says Dr. Conway. "Decreased length of stay and costs associated with clinical ... variability among hospitals in terms of length of stay, costs, readmission rates and test ... For example, older children had shorter length of stay and lower costs, and were less likely to ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... with three quality indicators, including length of hospital stay, cost of hospitalization, and ... and analyzed. Of these visits, the average length of stay was four days, costing an average of ... significantly increased mortality and a decreased length of hospital stay. Additionally, self-pay status ...

New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)

... between timing of drug initiation and length of exposure to treatment, and long-term outcomes. ... if two patients are treated for an equivalent length of time, the one who started therapy earlier in ... and to determine the relationship between length of drug exposure and long-term outcomes. The use ...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

... location within the hospital, antimicrobial use, length of hospitalization, mortality, and other ... Center. "There was also a trend toward reduced length of hospitalization in non-ICU patients with S. ... and reduces unnecessary antibiotic use, patient length of stay and hospital costs. About AdvanDx ...

Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

... . (Due to the length of this URL, please copy and paste it into your ... r (Due to the length of this URL, please copy and paste it into ... (Due to the length of this URL, please copy and paste it into your ...

Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease

... with multivessel disease was also diabetic, the length of the blockage was more than 100 mm or the ... with blockages that measured more than 100 mm in length (20 percent of the ARTS II patient population). ... CYPHER(R) Stents measuring 100 mm or less in length (p =0.15). A third analysis showed that ...

Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients

... has long been known to be associated with poor outcomes such as longer length of stay, increased rates of infection, and in-hospital death. ... of conventionally treated patients. The study showed no difference in length of time in the intensive care unit or in the hospital, or in other major ...

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

... density were secondary endpoints. Disease-free survival was defined as the length of time after randomization during which patients had no local recurrence, ... and/or death from any cause. Recurrence-free survival was defined as the length of time after randomization during which patients had no local recurrence, ...

Dallas Researchers Find Compression Stockings Improperly Used

... compression stockings and minimize adverse effects," Brosz said. "Knee length stockings have many practical advantages over thigh length in that they lower the risk of problems and health care costs. The ...

Menicon Undertakes With the Novovision Clinic a Paediatric Myopia Control Clinical Trial

... D were randomly allocated wear OK or SP correction. Measurements of axial length (using partial coherence interferometry, Zeiss IOLMaster), anterior ... at elucidating whether orthokeratology lens wear slows the axial length growth of the eye in children with progressing myopia. This study is of ...

First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System

... at Beaumont, Royal Oak. "This information tells us immediately what length of stent (tiny mesh "scaffold" to hold an artery open) to use and where ... rom _FDA.pdf) (due to the length of URL, please cut and paste into browser) approved The LipiScan Coronary ...

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting

... 67 percent of the lesions classified as complex B2/C, an average lesion length of 19.8 mm, and an average reference vessel diameter (RVD) of 2.6 mm. The ... and smallest RVDs compared to previous drug eluting stent trials. Lesion length and RVD are two important indicators of disease complexity. For the ...

Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings

... Hypertensive Patients with Chronic Kidney Disease: Hospital Costs and length of Stay Sandra Sulsky, M.P.H., Ph.D., ENVIRON International ... was conducted to determine the effect of anemia on hospital costs and length of stay in hypertensive patients with CKD. Analyses were adjusted for ...

BioCryst Updates Peramivir Clinical Development Plan

... pharmacokinetic studies have been completed that indicate that needle length impacts adequate and consistent systemic exposure to i.m. peramivir. These PK studies also provide guidance on the appropriate needle length to use in future studies to provide adequate drug exposure for subjects ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... face, tongue, or other parts of your body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the total dose received. This condition can also develop after a short period of treatment at low doses but this is less common. There ...

Is Your Hair Taking a Break?

... hair loss, the hair stays on the head for a shorter time due to a short growth phase, resulting in baby fine hairs that do not reach their full length or diameter. Fortunately, several treatment options are effective for women with hair loss. Minoxidil 2% is the only topical medication ...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect ...

Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy

... is available online at: http://www.informaworld.com/smpp/content~db=all~content=a910865593?words=kapl an&hash=843258562 (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) ...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

... reduces wound complications and hastens recovery time compared to traditional techniques that involve a long incision to expose the entire length of the vein. "In our experience, the impact of pre-heparinization on surgical bleeding is minimal, making it a promising strategy that may ...

Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology

... that the addition of vandetanib to docetaxel resulted in a statistically significant improvement in progression-free survival (PFS), the length of time a patient lives without their cancer growing (hazard ratio [HR] 0.79, 97.58% CI 0.70-0.90; P <0.001. Median PFS: 14.0 weeks vs. 17.3 ...

Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting

... tool, which facilitates arthroscopic insertion, allowing the surgeon to avoid invasive open procedures. The design also allows implants to be cut to length and easily hydrated with autologous blood products. The Company has also developed a full complement of specialized instruments to prepare the defect ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

... improvement in quality of life resulted in PCI as the dominant treatment strategy at one year. Results further showed that although the average length of hospital stay varied by country, CABG patients were hospitalized on average an additional 7.8 days compared to PCI patients (13.7 vs. 5.9 days, ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much ...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

... H, Fletcher C, Dimitrijevic S et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3: 655-64 (Due to the length of some of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one ...

Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma

... the company please visit http://www.octapharma.com/corporate/01_octapharma_news/07_news_2009/021609/oc tapharma_news_021609.html (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) ...

AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe

... bloodstream pathogens using PNA FISH tests leads to more appropriate patient therapy that saves lives and reduces unnecessary antibiotic use, patient length of stay and hospital costs. About AdvanDx AdvanDx is the world's leading provider of advanced molecular diagnostic products for the ...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

... previously. The goal of adding R7128 to the existing standard therapy is to improve rates of sustained virological response (SVR) and to shorten the length of treatment for patients. R7128 is being developed by Roche and Pharmasset under a partnership agreement entered into in 2004. The first ...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

... Without proper treatment, the associated complications of the disease can be deadly. Advanced age, gastrointestinal surgery/manipulation, long length of stay in healthcare settings, a serious underlying illness and compromised immunity are conditions associated with increased risk of disease. ...

Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain

... was the inspiration behind Arthri-Zen Relief Cream(R). "RZN Nutraceuticals decided to develop a pain relief cream because we weren't pleased with the length of relief provided by products that were currently on the market," said RZN Nutraceuticals President Robert Hunt. He should know. Hunt suffers from ...

For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold

... patients' arteriovenous (AV) fistulas -- vascular accesses needed for dialysis treatment -- responded just as well as those in younger patients -- in length of time the access stayed open and in moving blood flow efficiently. An AV fistula is the preferred access at any age," said Andrew R. Forauer, M.D., ...

ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease

... disease: The Brain Killer. WHO website: http://www.searo.who.int/en/Section1174/Section1199/Section1567/Section1823_8 066.htm (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) ...

IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile

... metacarpal runs to the little finger. According to Dr. von Unger, "With traditional methods of treating fractures, often an incision the full length of the fracture line has to be made; and plates and screws inserted to stabilize the fracture. There may be extensive soft tissue damage; the ...

Kensey Nash Announces IDE Submission for Cartilage Repair Device

... tool, which facilitates arthroscopic insertion, allowing the surgeon to avoid open procedures. The design also allows implants to be cut to length and easily hydrated with autologous blood products. The Company has also developed a full complement of specialized color-coded instruments to ...

Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial

... complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen ...

Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

... complexity of the human body cannot be perfectly, or sometimes, even adequately modelled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

... the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much ...

Oridion Announces Significant Medical Studies Presented at STA

... can be found on the Oridion website: http://www.oridion.com/global/english/clinical_solutions/overview/ research.html (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) ...

AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi

... 700 articles have been published in medical literature that support the benefits of AGA Medical devices, including improved patient outcomes, reduced length of stay, and accelerated recovery times for the patient. AGA Medical devices have received regulatory approval and are marketed in 101 countries. For ...
Other Contents
(Date:8/20/2014)... image of the Para and Mato Grosso states of ... set in order to deforest the land. Deforestation is ... where the land is thereafter converted to a nonforest ... farms, ranches, or urban use. The herringbone-patterned tan lines ... in the middle of the image are evidence of ...
(Date:8/20/2014)... Institutes of Health has awarded the Oklahoma Medical Research ... research on anthrax and the bacteria,s effects on humans. ... Ph.D., and his colleagues have studied the human immune ... Centers for Human Immunology. The original funding came soon ... the heels of the terrorist attacks of Sept. 11, ...
(Date:8/20/2014)... sunscreen and seawater signals a relaxing trip to the ... beach vacation comes with an environmental hitch. When certain ... they can become toxic to some of the ocean,s ... other marine animals. Their study appears in the ACS ... Tovar-Sanchez and David Snchez-Quiles point out that other than ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2
(Date:8/21/2014)... Los Angeles, CA (PRWEB) August 21, 2014 ... sleep doctors across the U.S. This provides doctors with a ... Patients who find a doctor are that much closer to ... this condition have no idea they are experiencing this ... do not receive treatment at all. , Thanks to Sleep ...
(Date:8/21/2014)... found that the low-expression variant of fatty acid-binding ... Finns, reduces the risk of heart attack and ... to customise a potentially preventive drug for atherosclerosis. ... long-term research project of the Department of Neurology ... (HUS) focuses on carotid atherosclerosis. It is a ...
(Date:8/21/2014)... August 21, 2014 ... Peripheral Vascular Devices Market by Angioplasty ... Catheter (IVUS, OCT), IVC Filter (Retrievable), ... 2018" analyzes and studies the major ... the U.S. and Canada. , Browse ...
(Date:8/21/2014)... Minn. (PRWEB) August 21, 2014 ... social wellness solutions, announced today that it has entered ... medical best practices, mobile technology and predictive analytics for ... communities. , According to Michael Emerson , ... applied for two patents on the technology used in ...
(Date:8/21/2014)... Jupiter, FL (PRWEB) August 21, 2014 ... Ed Begley, Jr., scheduled to broadcast on Monday, August ... PST, via Discovery Channel. , In this episode, ... Park encourages social participation and improves human performance. Audiences ... social sustainability for public spaces by installing and providing ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2Health News:A novel pathway for prevention of heart attack and stroke 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Hunhu Healthcare Enters into Licensing Agreement with Mayo Clinic 2Health News:Announcing New Episode Airing of Innovations on Monday August 25, 2014 via Discovery Channel 2
Other TagsOther Tags